In August 2020, the funding program "Viral Zoonoses - Innovative Approaches to Drug Development" was launched in response to the coronavirus pandemic. Now, the new call for proposals titled "Innovative Approaches to Antiviral Drug Development" introduces further funding opportunities for application-oriented drug research in Germany. The closing date for applications is February 17, 2022.
Dr. Dutow, how did the first round of calls for proposals for "Viral Zoonoses" go?
In the first round, the Foundation funded twelve projects with about 6.7 million euros. These extremely promising translational projects are currently being implemented. Overall, we are very satisfied: By the closing date for proposals, 37 applications had been received – amounting to a success rate of around 33%!
In terms of content, the funded topics reflect the continuing urgency to develop active substances especially against SARS-CoV2. Ten of the funded projects chose the corona virus as a therapeutic target. However, in response to current developments we decided to adapt the funding initiative.